跳至主要内容
临床试验/NCT01525654
NCT01525654终止不适用

Rheumatoid Arthritis Patient-to-Patient Connection Program

Brigham and Women's Hospital2 个研究点 分布在 1 个国家目标入组 65 人开始时间: 2009年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
65
试验地点
2
主要终点
change in functional status

研究概览

简要总结

The goal of PARASS is to develop a network of increased social support for Rheumatoid Arthritis (RA) patients that will improve patient outcomes and further promote understanding of RA among physicians and patients in the clinic community. This will be accomplished with the development and implementation of Buddy pairing and one -on- one informational support to be called Patient-to-Patient Connection.

详细描述

Rheumatoid arthritis (RA) is a chronic disabling disease that affects nearly 1% of the U. S. population [1]. The illness causes destruction of joint cartilage and erosion of adjacent bone, leading to joint replacement as well as extra-articular disease including cardiopulmonary manifestations, vasculitis, gastrointestinal and infectious complications [2]. Many patients with RA over time suffer progressive disability [3, 4], pain [5], work loss [3, 6], substantial health care costs [7], and premature mortality [8]. The current treatment of RA results in only modest improvements in functional status and many patients progress to chronic disability. Treatment is focused on ameliorating symptoms and halting disease progression as early as possible to prevent joint damage and functional decline.

Research has shown that while patient response to different medications may vary, those with chronic illness universally require social support and human empathy to achieve the best physical and emotional outcomes. From the 2006 PACO focus groups, we learned that RA patients' greatest concern was social isolation, that almost all had never talked with another person with RA, and that they feel alone dealing with the challenges of the disease. Psychosocial support is a seminal aspect of disease management since interpersonal relationships are often affected by the fatigue and physical disability of the disease and self-efficacy by the resulting loss of independence. The purpose of this study is to further patient care by providing social support services to better arthritis outcomes and patient satisfaction. In this pilot initiative called PARASS Patient-to-Patient Connection, patients will be able to connect with fellow patients who have similar concerns and fears and can find empathy and understanding based on personal experience. Buddy systems matching patients with similar needs or interests have been successful in addiction rehabilitation and oncology treatment, and group sessions have long been used as teaching and support tools in diabetes management. Rheumatology, however, has to date focused largely on providing patients with tools to improve the more physical manifestations of pain, swelling and fatigue. Furthermore, efforts to enhance self efficacy through leader initiated self help courses have not produced expected improvements in clinical outcomes. The purpose of this initiative is to develop a novel method of patient empowerment using peer support in order to better arthritis outcomes and patient satisfaction. To our knowledge, no rheumatology clinics in the United States have developed or instituted organized programs for peer social support or group informational discussion.

The goal of PARASS is to develop a network of increased social support for Rheumatoid Arthritis (RA) patients that will improve patient outcomes and further promote understanding of RA among physicians and patients in the clinic community. This will be accomplished with the development and implementation of a "buddy pairing" program called Patient-to-Patient Connection.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • billing diagnosis of rheumatoid arthritis (714.0) or seronegative inflammatory arthritis or a member of the BRASS and PACO studies at Brigham and Women's Hospital

排除标准

  • less than 18 years of age

研究组 & 干预措施

Partners

Active Comparator

Patients who are matched with support partners and have a billing diagnosis of RA (714.0) or seronegative inflammatory arthritis who are enrolled in the Brigham and Women's Rheumatoid Arthritis Sequential Study (BRASS) or the Patient-Centered Outcomes Initiative (PACO)

干预措施: Peer Support Program (Behavioral)

Controls

No Intervention

Controls will be BRASS patients who continue to receive regular care without being matched with a peer support partner.

结局指标

主要结局

change in functional status

时间窗: baseline and 6 months

functional status is measured by the Multi Dimensional Health Assessment Questionnaire doing scale and flare activity

change in medication adherence

时间窗: baseline and 6 months

assessed with the Adherence Barrier Survey-20 medication adherence questionnaire

次要结局

  • change in self-efficacy(baseline and 6 months)
  • change in fatigue(baseline and 6 months)
  • change in pain(baseline and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Nancy Shadick

Associate Professor

Brigham and Women's Hospital

研究点 (2)

Loading locations...

相似试验